Hormone Health Hub: Expert Insights on Testing, Balance & Better Living — lifestyle and breast cancer prevention

Single nucleotide variations (SNVs) in the enzymes that metabolise estrogen can significantly alter breast cancer risk — in some cases by as much as 12-fold when multiple variants combine. In this detailed scientific overview, Jillian Harrington PhD of ZRT Laboratory explains how variations in CYP11A1, CYP19A1 (aromatase), CYP1B1, COMT and MnSOD affect the estrogen metabolism pathway, why catechol estrogens are dangerous, and how methylation testing can reveal individual vulnerability.

One in eight women will be diagnosed with breast cancer in their lifetime. But many risk factors are modifiable — including hormone imbalance and excess weight. Discover the two most important actions women can take to reduce breast cancer risk, and how hormone testing can help identify hidden imbalances before they become a problem.